Can Fite Biopharma Ltd Long-term Investment Intensity
Can Fite Biopharma Ltd long-term investment intensity. Can Fite Biopharma Ltd (CANF) has a Long-term Investment Intensity of 9.9% as of September 2018. Long-term investments of ILA1.08 Million represent 9.9% of total assets of ILA10.82 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See working capital to net assets of Can Fite Biopharma Ltd to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Can Fite Biopharma Ltd (2017–2017)
Long-term investment intensity of Can Fite Biopharma Ltd from 2017 to 2017. This chart shows how Can Fite Biopharma Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of September 2018, the intensity stands at 9.9%, reflecting long-term investments of ILA1.08 Million against total assets of ILA10.82 Million ILA. See CANF days of operational coverage to measure how many days the company can operate on defensive assets alone.
Can Fite Biopharma Ltd Long-term Investment Intensity by Year (2017–2017)
Can Fite Biopharma Ltd long-term investment intensity by year from 2017 to 2017. The table below presents the year-by-year Long-term Investment Intensity for Can Fite Biopharma Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Can Fite Biopharma Ltd total assets.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 11.7% | ILA914.66K | ILA7.83 Million | — |